Status:
RECRUITING
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
Lead Sponsor:
University of Utah
Conditions:
Breast Cancer
Gynecologic Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The goal of this study is to assess the effect of brief mindfulness-guided meditations during radiation therapy (RT) for patients with anxiety related to RT for breast and gynecological cancers.
Eligibility Criteria
Inclusion
- Participant aged ≥ 18 years.
- Diagnosis of breast or gynelogical cancer.
- Eligible to receive 15-25 daily radiation therapy treatments for breast or gynelogical cancer.
- Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
- Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
- Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.
Exclusion
- Active suicidal ideation or active psychotic state in the opinion of the investigator.
- Patient is receiving deep inspiration breath hold treatment.
- An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
- Prior radiation therapy.
- Inability to understand and/or speak the English language.
Key Trial Info
Start Date :
September 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2028
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT07166042
Start Date
September 25 2025
End Date
September 30 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States, 84112